Corneal blindness affects roughly 13 million people worldwide. The primary treatment option for corneal blindness is corneal transplantation, which happens to be the most common donor tissue transplant. To address all of the challenges presented by corneal blindness, we must recognize the emotional and financial burden this disease can have on populations, particularly those in lower to middle-income countries where access to eyecare is limited. By raising awareness of corneal blindness and the need for more innovative treatment options, we strive to improve the health outcomes for all patients with corneal blindness globally. #cornealblindness #ophthalmology #cornealtransplant
This content isn’t available here
Access this content and more in the LinkedIn app
